Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ANIX — Anixa Biosciences Inc

CIK 72971 SAN FRANCISCO, CA
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$33,600
+$2,640 QoQ
Shares Held
12,000
0.0% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 62 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ANIX ranks #301 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ANIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,600 12,000
2026-03-31 $30,960 12,000
2025-12-31 $37,440 12,000
2025-09-30 $34,650 10,500
2025-06-30 $34,650 10,500
2025-03-31 $24,310 8,500
2024-12-31 $19,720 8,500
2024-09-30 $26,775 8,500
2024-06-30 $18,785 8,500
2024-03-31 $2,333 748
2023-12-31 $2,867 739
2023-09-30 $2,374 726
2023-06-30 $2,313 723
2023-03-31 $3,070 714
2022-12-31 $7,263 1,709
2022-09-30 $3,453 702
2022-06-30 $2,148 702
2022-03-31 $1,876 685
2021-12-31 $2,031 684
2021-09-30 $29,501 6,185
2021-06-30 $24,017 6,190
2021-03-31 $28,824 6,159
2020-12-31 $3,518 1,146
2020-09-30 $17,461 7,186
2020-06-30 $24,369 7,964
2020-03-31 $12,851 8,083